To assess astrocyte cytoskeletal structure, we immunohistostained for GFAP in the peri-infarct area during the acute (24 h) and subacute (7 days) phases following dMCAO, and the chronic (30 days) phase after photothrombotic stroke (Figures 2A, C, E). This evidence concerns the gene GFAP and stroke disorder.